Dailypharm Live Search Close

Winner of pricing suits will be compensated for damages

By Kim, Jung-Ju | translator Alice Kang

21.11.26 06:18:55

°¡³ª´Ù¶ó 0
MOHW reports to HIPDC that it will implement a refund system for lawsuits

36 delays in price cuts occurred during the past 3 years due to stay of executions¡¦ causing ₩400 billion fiscal damage

Bill prepared to clarify remedies provided for damages incurred by companies¡¦may choose lump sum or price raise


The countless litigations between government and companies regarding reimbursements such as drug price cuts or reduced scope of reimbursement are causing wasteful losses to both parties.

On this, the government and the National Assembly have been proposing various solutions to prevent excessive stay of executions.

The NA has proposed an amendment to the National Health Insurance Act which allows government authorities to recover the reflective profits the companies accrued during the suspension of execution period if it wins the main lawsuit, and refund them to companies when vice versa after a pharmaceutical company applies for administrative litigation and suspension of execution in op

Kim, Jung-Ju(jj0831@dailypharm.com)
If you want to see the full article, please JOIN US (click)